小型猪胰淀素基因的多态性分析

目的探讨我国3个特有的小型猪品系,巴马小型猪,五指山小型猪,中国农大小型猪胰淀素（IAPP）基因多态性分布,为我国小型猪在2型糖尿病及代谢性疾病研究中的应用提供基础资料。方法提取3个品系小型猪血液基因组DNA,针对IAPP基因外显子3~内含子3的部分序列进行PCR扩增,产物鉴定、测序,统计分析基因多态。结果在所扩增的片段中共检测出2个SNPs位点,SNPs1：43G→A,位于外显子上,未引起的氨基酸的改变,突变发生在五指山猪（G/A杂合突变为16.7%,A纯合突变为83.3%）和中国农大猪（G/A杂合突变60%,A纯合突变为20%两个品系中。SNPs2：214C→T,位于内含子上,发生在五指山猪（T/C杂合突变为16.7%,T纯合突变为83.3%）和中国农大猪（T/C杂合突变为20%,T纯合突变为60%）两个品系中。结论在IAPP基因外显子3-内含子3的部分扩增序列中发现了2个SNPs位点,在3个品系小型猪中的分布不同。     

巴马小型猪TNF-α基因的克隆与相关生物学信息分析

本研究旨在分析巴马小型猪TNF-α(tumor necrosis factor-alpha)基因的遗传变异情况。实验采用RT-PCR和克隆的方法成功扩增TNF-α基因的编码区序列,同时对TNF-α基因和相应的蛋白序列进行生物信息学分析。结果表明,巴马小型猪TNF-α基因编码区全长为699 bp,编码232个氨基酸;与Gen Bank中已发表的猪TNF-α基因(登录号:NM_214022.1)序列进行比对,未发现核苷酸碱基突变;编码的232个氨基酸分子量为25 253.9,理论等电点为5.44,不存在信号肽,但存在跨膜螺旋结构。经过序列相似性分析,巴马小型猪的TNF-α基因与猪、人、马、牛、家犬、绵羊同源性比较结果表明其具有较强的保守性。巴马小型猪的TNF-α基因与野猪的亲缘关系一致。     

小型猪葡萄糖转运子4外显子4a的基因多态性分析

目的分析我国特有的3个小型猪品系巴马小型猪、中国农大小型猪、五指山小型猪葡萄糖转运子4基因外显子4a的单核苷酸多态性（SNPs）分布特点,为我国小型猪在糖尿病和代谢性疾病研究中提供基础资料。方法以3个品系小型猪基因组DNA为模板,应用特异性引物进行PCR扩增,扩增产物纯化测序,进行BLAST比对分析。结果在小型猪GLUT-4基因外显子4a上有2个SNP位点：SNP1：GCT→GCC（Ala133 Ala）,3个品系均发生了变化,均为纯合突变,其突变率为（22/22,100%）。SNP2：GGC→GGT（Gly146 Gly）,巴马小型猪突变率为（6/6,100%）,均为纯合突变;五指山小型猪突变率为（6/6,100%）,均为纯合突变;中国农大小型猪突变率为（10/10,100%）,其中包括6例纯合突变（6/10,60%）和4例杂合突变（4/10,40%）。结论SNPs1,在所有测定的小型猪品系中检出,这可能是所测小型猪的共有特征。SNPs2可能是小型猪品系之间的差异。     

猪Pit-1基因第三内含子序列的克隆测序

根据不同物种间同一基因核苷酸序列的保守性及相似性的特点 ,在人和鼠的Pit 1基因第三外显子上设计上游引物 ,而将下游引物设计在猪Pit 1基因第四外显子上。利用聚合酶链式反应 (PCR)技术 ,扩增出猪Pit 1基因第三内含子序列 ,并经由酶切及序列同源性比对确认该序列即为猪Pit 1基因第三内含子序列。此序列的确定为下一步进行遗传变异分析的研究奠定了基础     

用RACE技术快速扩增五指山猪来源的猪内源性反转录病毒3'LTR

测定我国小型猪来源的猪内源性反转录病毒(PERV)3'LTR,以便于PERV全基因的克隆和分析.用cDNA末端快速扩增(RACE)技术,从五指山猪外周血淋巴细胞mRNA中扩增到PERV-3'LTR,并克隆入pGEM-T easy载体,将阳性克隆进行序列测定和同源性分析.测序结果显示该克隆3'端的尾部有一个由12个A组成的poly(A)信号;其R区与PERV-MSL的R区(约64 bp)基本一致,同源性分析表明其与PERV-MSL的3'LTR具有81%的序列同源性.说明成功扩增了我国五指山猪来源的PERV-3'LTR,将有利于PERV全基因的克隆.     

实验用西藏小型猪CYP3A基因的克隆及序列分析

目的:克隆西藏小型猪CYP3A基因并与人及其它小型猪品种进行序列比对分析。方法:根据Genebank数据库设计引物,取西藏小型猪新鲜肝脏组织,Trizol法提取肝脏总RNA,应用RT-PCR反转获得肝脏cDNA。分别扩增基因CYP3A46、CYP3A22、CYP3A29及CYP3A39,PCR片段回收后分别连接pMD-18T载体,获得重组质粒pT-CYP3A,阳性重组克隆送测序。采用NCBI Blast及vector NTI软件进行序列比对分析。结果:CYP3A46、CYP3A22、CYP3A29及CYP3A39基因编码序列全长1512 bp,编码503个氨基酸,与人CYP3A4相同。其中CYP3A22和CYP3A39与NCBI记录巴马小型猪序列相同;CYP3A46与巴马小型猪CYP3A46(NM_001134824.1)有6个位点碱基不同。CYP3A29与巴马小型猪CYP3A46(EU918131.1)亦有6个位点碱基不同。对来自2个母本后代猪的基因经过PCR扩增后测序发现CYP3A46、CYP3A29序列完全一致。结论:成功克隆西藏小型猪CYP3A的4个基因,其中CYP3A46与人CYP3A4的序列相似性最高。所得CYP3A46与CYP3A29序列可能为西藏小型猪独有。     

用RACE技术快速扩增五指山猪来源的猪内源性反转录病毒3＇LTR

测定我国小型猪来源的猪内源性反转录病毒(PERV)3'LTR,以便于PERV全基因的克隆和分析。用cDNA末端快速扩增(RACE)技术,从五指山猪外周血淋巴细胞mRNA中扩增到PERV-3'LTR,并克隆入pGEM-Teasy载体,将阳性克隆进行序列测定和同源性分析。测序结果显示该克隆3'端的尾部有一个由12个A组成的poly(A)信号;其R区与PERV-MSL的R区(约64bp)基本一致,同源性分析表明其与PERV-MSL的3'LTR具有81%的序列同源性。说明成功扩增了我国五指山猪来源的PERV-3'LTR,将有利于PERV全基因的克隆。     

西藏小型猪IGF-1基因的克隆测序分析

目的克隆西藏小型猪的肝脏组织中的IGF-1基因的c DNA序列,并与Pubmed中查询到的猪c DNA进行比对分析。方法提取了西藏小型猪肝脏组织的总RNA,应用RT-PCR技术扩增了IGF-1基因的c DNA序列,将扩增出的片段克隆到p MD18-T载体上,构建重组质粒p MD18-T-IGF-1,进行测序分析。结果克隆出西藏小型猪肝脏组织中的IGF-1的c DNA序列,获得了大小为567 bp长的片段,编码了186个氨基酸,与Pubmed中查询到的猪(NM_214256.1)的IGF-1基因高度同源,比对序列发现,在440、455 bp处发生了G→A、C→T的突变,该位点的突变引起相应编码氨基酸的变化,分别由组氨酸变成了精氨酸、亮氨酸转变成了丝氨酸。结论为西藏小型猪的生长发育机制研究提供了分子学依据。两个位点的突变引起的氨基酸的改变是否是导致西藏小型猪矮小的原因,需要进一步论证。     

广西巴马小型猪PGC-1α基因克隆与组织表达分析

目的克隆广西巴马小型猪PGC-1α基因编码区（CDS）序列,利用RT-PCR和QRT-PCR方法分析PGC-1αmRNA组织表达情况。方法本实验以广西巴马小型猪背最长肌cDNA为模版,PCR扩增PGC-1α基因CDS序列,将其连接至pEASY-T5载体,转染细菌、验证和序列测定;通过RT-PCR半定量和QRT-PCR实时荧光定量检测PGC-1α基因在小型猪多个组织中的表达情况。结果克隆获得广西巴马小型猪PGC-1α基因CDS序列,全长2391 bp,编码796个氨基酸,与参考序列的同源性为99.9%,两处碱基发生同义突变,分别是C-A1105和GA1524;PGC-1α基因在广西巴马小型猪心脏和肾脏中的表达丰度最高,其次是肝脏、皮下脂肪和背最长肌,而在胰腺中未检测到其表达。结论成功克隆了广西巴马小型猪PGC-1α基因编码区序列并进行了多种组织表达分析,为后续研究PGC-1α在小型猪2型糖尿病发生过程中作用途径打下基础。     

猪圆环病毒2型福建株的全基因组克隆与序列分析

根据GenBank上公布的猪圆环病毒2型全基因序列设计一对扩增PCV-2全基因的引物,建立扩增PCV-2全序列的PCR方法,并应用此方法从福建省不同地区采集的疑似断奶仔猪多系统衰竭综合征(PMWS)的仔猪肺组织病料中扩增出PCV-2全基因组(1 767 bp),将此基因片段克隆入pMD 18-T载体,筛选获得重组质粒pMD-PCV-2,并对其进行序列测定,然后对全基因组进行同源性和遗传进化分析。结果表明,福建省不同地区采集的猪肺组织扩增出的PCV-2全序列与GenBank上公布的的全基因组同源性介于94.9%-99.8%之间,ORF1的同源性介于97.2%-99.9%,ORF2的同源性也很高,介于97.7%-99.8%之间。其中福州株、福清株和漳州株与中国农大报道的12株、郑州株5株、杭州4株、武汉株3株、上海株2株、扬州2株、南京1株和兰州1株共30株在一个进化分支上,同源性也高达99.3%。本研究有助于监测PCV-2的疫源和进化关系,为进一步深入研究福建省生猪猪圆环病毒来源奠定一定基础。     

Islet amyloid polypeptide: identification and chromosomal localization of the human gene

Islet or insulinoma amyloid polypeptide (IAPP) is a 37 amino acid polypeptide isolated from pancreatic amyloid. Here, we describe the isolation and partial characterization of the human gene encoding IAPP. The DNA sequence predicts that IAPP is excised from a larger precursor protein and that its carboxy-terminus is probably amidated. The predicted normally occurring IAPP is identical to the reported polypeptides isolated from pancreatic amyloid, except for the amidated carboxy-terminus. IAPP specific polyadenylated RNAs of 1.6 kb and 2.1 kb are present in human insulinoma RNA. The human IAPP gene is located on chromosome 12.     

Amyloid in the pancreatic islets of the cougar (Felis concolor) is derived from islet amyloid polypeptide (IAPP)

1. Islet amyloid isolated from the pancreas of a 20-year-old cougar (Felis concolor) was dissolved and purified by gel permeation and reversed phase HPLC for amino acid sequence analysis. 2. N-Terminal amino acid sequence analysis of the purified protein revealed a primary structure (positions 1-28) identical to islet amyloid polypeptide (IAPP) from domesticated cats. 3. IAPP from the cougar, like IAPP from the human and domesticated cat, incorporates an inherently amyloidogenic AILS sequence at positions 25-28.     

Islet amyloid polypeptide (IAPP) competes for two binding sites of CGRP.

Two distinct binding sites for [125I]human calcitonin gene-related peptide (hCGRP) were found in rat brain, skeletal muscle, and liver. Each tissue had a high affinity site with an average Kd of 46 pM and a low affinity site with an average Kd of 22 nM. Islet amyloid polypeptide (IAPP), which has N- and C-terminal sequence homology to CGRP and is produced by islet beta-cells, bound to both sites but had a potency closer to that of CGRP at the low affinity binding site. A C-terminal fragment of IAPP competed for [125I]hCGRP binding at the low affinity site with potency comparable to that of hIAPP. No specific binding to membrane preparations was found in experiments using [125I]rIAPP, which was iodinated at the C-terminal tyrosyl residue. These results suggest that some of the previously reported biological effects occurring at nM or microM concentrations of IAPP may be mediated by IAPP binding to low affinity CGRP receptors. This study further indicates that the C-terminal region of IAPP is important for binding to low affinity CGRP receptors, and suggests that C-terminal fragments of IAPP may be of biological importance.     

Biosynthesis of islet amyloid polypeptide. Elevated expression in mouse beta TC3 cells

Islet amyloid polypeptide (IAPP) messenger RNA levels, biosynthesis, processing, and secretion were studied in cultured mouse beta TC3 insulinoma cells. Northern blot analysis revealed that the size of IAPP mRNA (0.9 kb) in beta TC3 cells was the same as that in normal mouse islets; IAPP mRNA was approximately 60% of the level of insulin mRNA in beta TC3 cells. However, the ratio of synthesis of insulin to IAPP was approximately 6:1, suggesting that IAPP mRNA is not translated efficiently in these cells. Metabolic labeling of beta TC3 cells with [3H]leucine revealed the synthesis of both a precursor form of IAPP (pro-IAPP) of apparent Mr 7400 and a mature form (IAPP) of apparent Mr 3900. In pulse-chase experiments, pro-IAPP could be shown to be processed to IAPP in a manner similar to proinsulin. The t1/2 for conversion of pro-IAPP to IAPP was about 25 min, faster than the t1/2 for proinsulin to insulin of 70 min. A significant proportion of newly synthesized IAPP and insulin precursors were secreted via a constitutive pathway from beta TC3 cells. Possible effects of dexamethasone and forskolin on IAPP mRNA levels and biosynthesis were examined but no effects were observed. In conclusion, the IAPP gene is strongly expressed in beta TC3 cells leading to the biosynthesis, proteolytic processing, and secretion of IAPP, a putative islet hormone.     

Direct measurement of islet amyloid polypeptide fibrillogenesis by mass spectrometry

A novel method for monitoring fibrillogenesis is developed and applied to the amyloidogenic peptide, islet amyloid polypeptide (IAPP). The approach, based on electrospray ionization mass spectrometry, is complementary to existing assays of fibril formation as it monitors directly the population of precursor rather than product molecules. We are able to monitor fiber formation in two modes: a quenched mode in which fibril formation is halted by dilution into denaturant and a real time mode in which fibril formation is conducted within the capillary of the electrospray source. Central to the method is the observation that fibrillar IAPP does not compromise the ionization of monomeric IAPP. Furthermore, under mild ionization conditions, fibrillar IAPP does not dissociate and contribute to the monomeric signal. Critically, we introduce an internal standard, rat IAPP, for analysis on the mass spectrometer. This standard is sufficiently similar in sequence in that it ionizes identically to human IAPP. Furthermore, the sequence is sufficiently different in that it does not form fibrils and is distinguishable on the basis of mass. Applied to IAPP fibrillogenesis, our technique reveals that precursor consumption in seeded reactions obeys first-order kinetics. Furthermore, a consistent level of monomer persists in both seeded and unseeded experiments after the fibril formation is complete. Given the inherent stability of fibrils, we expect this approach to be applicable to other amyloid systems.